On Thursday, Russia’s Supreme Court dismissed a case filed by Gilead Sciences, contesting the Russian government’s decision last year to allow a Russian pharmaceutical business to develop the COVID-19 medicine remdesivir without Gilead’s agreement.
According to Reuters, as part of its humanitarian relief donations, Pharmasyntez dispatched a generic version of the medicine, named Remdeform, to India on Tuesday.
